Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

According to a study published in Biomaterials Advances, scientists at the University of Copenhagen have developed a patch ...

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

The agency said that J&J’s recent moves to change payment terms for its Xarelto blood thinner and the Stelara plaque psoriasis treatment are unlawful as they would require the hospitals to purchase ...

A dermatophyte known as Trichophyton mentagrophytes genotype VII (TMVII) has been identified as the cause of an emerging ...

Presented data at EADV supporting potential of ESK-001 as differentiated oral treatment in immune-mediated diseases through maximal TYK2 inhibition – – Continued to advance three clinical programs, ...

Against the background described above, "betting big" on a topical treatment for plaque psoriasis make a lot of sense, ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

psoriasis, sun rash etc). By educating patients on preventative measures and treatment strategies for common skin diseases, ...

U.S. Dermatology Partners is pleased to announce the opening of its newest location in Crockett, Texas. Beginning November 13th, 2024, the office will treat a wide range of dermatologic conditions, ...